Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment
Author:
Wilson John J.,
Wei Jian,
Daamen Andrea R.,
Sears John D.,
Bechtel Elaine,
Mayberry Colleen L.,
Stafford Grace A.,
Bechtold Lesley,
Grammer Amrie C.,
Lipsky Peter E.,
Roopenian Derry C.,
Chang Chih-HaoORCID
Funder
US Department of Defense
The Jackson Laboratory
Subject
Multidisciplinary